The University of Chicago Header Logo

Connection

Rolf Barth to Ganciclovir

This is a "connection" page, showing publications Rolf Barth has written about Ganciclovir.
Connection Strength

0.106
  1. Valganciclovir is an effective prophylaxis for cytomegalovirus disease in liver transplant recipients. HPB (Oxford). 2010 Dec; 12(10):657-63.
    View in: PubMed
    Score: 0.092
  2. Experimental treatment of Epstein-Barr virus-associated primary central nervous system lymphoma. Cancer Res. 2003 Mar 01; 63(5):965-71.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.